Jochen Reinoehl, Chief Executive Officer
Professional Overview
Jochen Reinoehl is an accomplished medical professional with extensive experience in the healthcare industry. As the Chief Executive Officer at Coramaze, he leverages his deep expertise in cardiology and medical device development to drive innovation and growth within the organization.
Experience Summary
Current Role
As the Chief Executive Officer at Coramaze, Jochen is responsible for setting the strategic vision and overseeing the company's operations. He is focused on developing and commercializing novel transcatheter mitral and tricuspid valve therapies to improve patient outcomes. Under his leadership, Coramaze is poised to make a significant impact in the structural heart disease market.
Career Progression
Prior to his current role, Jochen held several senior-level positions in the healthcare industry. As the Chief Medical Officer and Managing Director Europe at Hawthorne Effect, Inc., he was instrumental in advancing the company's medical device innovations. He previously served as the Chief Medical Officer at Xeltis, where he led the development of groundbreaking heart valve products. Jochen also has extensive experience in medical affairs and professional education, having held leadership roles at Edwards Lifesciences and the University of Freiburg.
Academic Background
Jochen Reinoehl earned his medical degree from the University of Freiburg, where he also completed his residency in internal medicine and cardiology. He is a highly regarded expert in the field of structural heart disease and has made significant contributions to advancing research and clinical practice in this area.
Areas of Expertise
- Structural heart disease management
- Transcatheter mitral and tricuspid valve therapies
- Medical device development and commercialization
- Clinical trial design and execution
- Medical affairs and professional education
- Strategic leadership and operational management
Professional Impact
Throughout his career, Jochen Reinoehl has demonstrated a track record of driving innovation and clinical excellence. He has been involved in the development and successful commercialization of several groundbreaking medical devices, and his research and publications have made significant contributions to the field of cardiology. Jochen's expertise and strategic vision have positioned him as a respected leader in the healthcare industry.
Conclusion
With his extensive background in cardiology, medical device development, and executive leadership, Jochen Reinoehl is well-equipped to guide Coramaze towards new heights. His commitment to advancing patient care and his proven ability to drive organizational growth make him a valuable asset to the company and the broader healthcare community.
